ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

BHST // BioHarvest Sciences Inc.

FA <GO> NASDAQ RQD COCKPIT → CIK 0001723464 ↗
Industrials • Diversified Equities
$1.66 ▼ -0.10 (-5.68%)
MKT CAP: $37.6M • VOL: 20.4K
BHST // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
FY 2024
FILED 2024-12-31
FY 2023
FILED 2023-12-31
Revenue (Total Sales) $34.5M $25.2M $12.7M
YoY Revenue Growth % +37.0% +98.8% —
Gross Profit $20.5M $13.9M —
Gross Margin % 59.3% 55.4% —
Research & Development (R&D) — — —
Operating Income (EBIT) -$5.6M -$7.0M -$10.0M
Operating Margin % -16.2% -27.7% -78.6%
Net Income (GAAP) -$11.1M -$12.9M -$12.6M
EBITDA (Normalized) -$3.7M -$4.7M —
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) -$7.2M -$6.7M -$8.5M
Capital Expenditures (CapEx) $2.4M $2.8M —
Free Cash Flow (FCF) -$9.6M -$9.5M -$8.5M
FCF Margin % -27.8% -37.8% -67.3%
Return on Invested Capital (ROIC %) -45.0% -45.0% —
Cash & Short-Term Equivalents $23.0M $2.4M —
Total Debt (Short + Long Term) — — —
Total Stockholders' Equity $25.4M $1.3M —